| 摘要 |
This invention is related to a novel ammonium chloride and trimethylammonium chloride combination and use thereof, as a therapeutic agent for the treatment or prophylaxis of viral infections, more pareficiency Virus-caused Acquired Immunodeficiency Syndrome.
|
